Harsco Corp (NYSE: HSC) has reported a loss for its first fiscal quarter (ending March 31) of $-0.21 versus a loss $-0.11 for the same period a year ago. Relative to the consensus estimate of […]
Granite Construction Inc. (NYSE: GVA) has reported E.P.S. of $-0.70 for its first fiscal quarter (ending March 31) versus $-0.53 for the same period a year ago. For the latest four quarters through March 31, […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $19.94 on 5/2/24 after a major increase of 10.5%. Moreover, exceptionally high trading volume at 216% of normal accompanied the advance. Relative to the market the stock […]
For its first fiscal quarter (ending March 31), EOG Resources Inc. (NYSE: EOG) has reported a -10% decline in E.P.S. from $3.46 a year ago to $3.11 in the current quarter. However, this result exceeded […]
On 5/2/24, Climb Global Solutions Inc (NASDAQ: CLMB) stock suffered a major decline of -10.5%, closing at $59.09. Moreover, this decline was accompanied by exceptionally high trading volume at 457% of normal. Relative to the […]
For its first fiscal quarter (ending March 31), Cinemark Holdings Inc (NYSE: CNK) has reported E.P.S. of $0.20 compared to $-0.03 a year ago. This result exceeded the consensus estimate of $-0.02 by $0.22. For […]
Bruker Corporation (NASDAQ: BRKR) has reported E.P.S. of $0.35 for its first fiscal quarter (ending March 31) versus $0.52 for the same period a year ago — a decline of -33%. This result fell short […]
Blueprint Medicines Corp (NASDAQ: BPMC) has reported earnings for its first fiscal quarter (ending March 31) of $1.45 versus a loss $-2.15 for the same period a year ago. This performance was $2.66 better than […]
Benchmark Electronics Inc (NYSE: BHE) stock closed at $35.76 on 5/2/24 after a major increase of 18.1%. Moreover, exceptionally high trading volume at 223% of normal accompanied the advance. The stock has risen 16.9% during […]
Baxter International Inc (NYSE: BAX) has reported earnings for its first fiscal quarter (ending March 31) of $0.07 versus $0.00 for the same period a year ago. This result fell short of the consensus estimate […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research